Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)
Price and Volume
Detailed Quote| Volume | 94,018 |
| Open | 18.82 |
| Bid (Size) | 19.09 (100) |
| Ask (Size) | 19.26 (1,500) |
| Prev. Close | 18.92 |
| Today's Range | 18.82 - 19.62 |
| 52wk Range | 11.09 - 23.00 |
| Shares Outstanding | 25,688,062 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Eton Pharma (ETON) Q3 2025 Earnings Transcript ↗
November 09, 2025
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 06, 2025
Eton (ETON) Q2 Revenue Jumps 108% ↗
August 07, 2025
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
Frequently Asked Questions
Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?
Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market
What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?
The current price of Eton Pharmaceuticals, Inc. - Common Stock is 19.15
When was Eton Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 03/18/26 01:42 PM ET
What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 491.93M
How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?
Eton Pharmaceuticals, Inc. - Common Stock has 492M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube